Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL108513 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL377101 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL17003993 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL11213774 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL1780545 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL35912 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL6756329 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL9931816 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| Hexane SCHEMBL6049081 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL57407 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1651 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260000623-A1 | DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES | CHAN, Hardy Wai Hong (TW) | 2026-01-01 | — | — | US | claimed |
| CN-119838434-A | Method for forming compact cortex on surface of PP or PMP hollow fiber membrane | 杭州百腾环境科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| WO-2024263122-A1 | SUPERHYDROPHOBIC AND SUPEROLEOPHILIC COMPOSITE SPONGE MATERIAL AND THE PRODUCTION METHOD THEREOF | AKDENIZ UNIVERSITESI (TR) | 2024-12-26 | — | — | WO | claimed |
| CN-114730023-B | Substrate with antiglare layer, image display device, and method for producing substrate with antiglare layer | 日产化学株式会社 | 2024-11-01 | — | — | CN | claimed |
| EP-4358119-A2 | IMPROVED SELF-ASSEMBLED MONOLAYER BLOCKING WITH INTERMITTENT AIR-WATER EXPOSURE | Applied Materials, Inc. (US) | 2024-04-24 | — | — | EP | claimed |
| US-11903767-B2 | Composite tissue markers detectable via multiple detection modalities | VIEW POINT MEDICAL, INC. (US) | 2024-02-20 | — | — | US | claimed |
| US-11882992-B2 | Composite tissue markers detectable via multiple detection modalities including radiopaque element | VIEW POINT MEDICAL, INC. (US) | 2024-01-30 | — | — | US | claimed |
| CN-112239209-B | Drug delivery via pore-modified mesoporous silica nanoparticles | 奈力生医股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-117334560-A | Improved self-assembled monolayer blocking with intermittent air-water exposure | 应用材料公司 | 2024-01-02 | — | — | CN | claimed |
| CN-115433461-B | Heat-conducting silicone grease with low oil separation rate and long storage life and preparation method thereof | 矽时代材料科技股份有限公司 | 2023-11-24 | — | — | CN | claimed |
| US-20030125419-A1 | Silane-modified oxidic or silicate-like filler, process for its preparation, and its use | DEGUSSA AG (DE) | 2003-07-03 | — | — | US | claimed |
| US-6512035-B1 | A reinforcing filler comprising silica of a mixture thereof with carbon black; a processing aid comprising a monofunctional alkyl tin compound, in the absence of a polysulfide silica coupling agent; a cure agent; and an | BRIDGESTONE CORPORATION (JP) | 2003-01-28 | — | — | US | claimed |
| US-6313210-B1 | FOR PNEUMATIC TIRES, POWER BELTS | BRIDGESTONE COPORATION (JP) | 2001-11-06 | — | — | US | claimed |
| EP-0674237-B1 | Toner for developing an electrostatic image | CANON KK (JP) | 2000-05-31 | — | — | EP | claimed |
| US-5800926-A | REACTION PRODUCT OF TETRAALKYL SILICATE, FLUOROALKYLTRIALKOXYSILANE, ALCOHOL AND OXALIC ACID | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1998-09-01 | — | — | US | claimed |
| US-5766673-A | POLYSILOXANES MODIFIED WITH AN ALCOHOL AND OXALIC ACID | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1998-06-16 | — | — | US | claimed |
| EP-0790522-A1 | Process for forming a liquid crystal vertical alignment film | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1997-08-20 | — | — | EP | claimed |
| EP-0776925-A2 | Coating film having water repellency and low refractive index | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1997-06-04 | — | — | EP | claimed |
| US-5635326-A | COLORANT-CONTAINING PARTICULATE RESIN AND TITANIUM OXIDE AND AN ALKYL TITANATED TREATED WITH A SILANE-TYPE ORGANIC COMPOUND; SHARPNESS; ANTIFOGGING AGENTS; DURABILITY; COPIERS; ELECTROPHOTOGRAPHY | CANON KABUSHIKI KAISHA (JP) | 1997-06-03 | — | — | US | claimed |
| EP-0674237-A1 | Electrostatic image-developing toner, fine powdery titanium oxide, and hydrophobic fine powdery titanium oxide | CANON KABUSHIKI KAISHA (JP) | 1995-09-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000623-A1 | DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES | AQP4, ABCB1, SRMS | LMNA 1004/4885TSHR 3081/4885THRB 3746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.